Author: UKPBC

Over the course of 2015 there was extensive discussion about whether the name of PBC should be changed from Primary Biliary Cirrhosis to Primary Biliary Cholangitis. The majority of PBC …

Gwilym Webb, Research Fellow, University of Birmingham, Jessie Dyson, Research Fellow, Newcastle University As the British weather eased towards mid-spring sun, the first UK-PBC meeting opened at the Royal College of …

The Practice to Policy(tm) Health Award Program is currently open and accepting applications in the U.S., Europe and Canada. Applications are being sought from academic institutions, healthcare, policy and patient …

In an interview with the MRC, Professor Jones explains why it is vitally important for academic and industry researchers to collaborate, and how UK-PBC is at the forefront of this. Please refer …

The strength of UK-PBC partnerships (academic, industry, patient and funders) will feature as an illustration of how vital partnerships are in research. UK-PBC achievements relating to this will feature in …

The calculator uses information from the UK-PBC Research Cohort to estimate the risk (expressed in percentage) that a PBC patient established on treatment with Ursodeoxycholic acid (UDCA) will develop liver …

The trial is now closed to recruitment and on behalf of Prof Jones and the team we would like to thank all participants who volunteered, the study is still on-going …

The RITPBC clinical trial which is investigating Rituximab as a treatment for severe fatigue is closing to recruitment at the end of September 2015. If anyone has been considering the …